Here, we provide an overview of the more promising fluid biomarkers for ALS, highlight exciting new strategies towards testing the utility of TDP-43—a protein intimately involved in ALS pathogenesis—as a reliable biomarker, and discuss present limitations and future avenues being explored for ALS biomarker discovery. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.